ID

26116

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Pharmacogenetic research Withdrawal of consent

Keywords

Versions (4)
  1. 10/9/17 10/9/17 -
  2. 10/16/17 10/16/17 -
  3. 10/23/17 10/23/17 -
  4. 1/11/18 1/11/18 -
Copyright Holder

GlaxoSmithKline

Uploaded on

October 9, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

No comments

In order to download data models you must be logged in. Please log in or register for free.

Pharmacogenetic research Withdrawal of consent GSK study Chronic Coronary Heart Disease NCT00799903

English

Pharmacogenetic research Withdrawal of consent Subject Identification GSK study Chronic Coronary Heart Disease NCT00799903

1 forms  
Withdrawal of consent for PGx (DNA) / Blood sample destruction
Description

Withdrawal of consent for PGx (DNA) / Blood sample destruction

1. Has subject withdrawn consent for PGx research?
Description

withdrawal consent for PGx research

Data type

boolean

If subject has withdrawn consent for PGx research: date informed consent withdrawn
Description

date informed consent withdrawn

Data type

date

2. Has a request been made for blood sample destruction?
Description

request for blood sample destruction

Data type

boolean

If a request has been made for blood sample destruction, check reason
Description

request for blood sample destruction reason

Data type

text

If other reason applied, specify
Description

request for blood sample destruction other reason

Data type

text

Back to the top of the page

Similar models

Pharmacogenetic research Withdrawal of consent Subject Identification GSK study Chronic Coronary Heart Disease NCT00799903

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Withdrawal of consent for PGx (DNA) / Blood sample destruction
withdrawal consent for PGx research
Item
1. Has subject withdrawn consent for PGx research?
boolean
date informed consent withdrawn
Item
If subject has withdrawn consent for PGx research: date informed consent withdrawn
date
request for blood sample destruction
Item
2. Has a request been made for blood sample destruction?
boolean
Item
If a request has been made for blood sample destruction, check reason
text
undefined item
Code List
If a request has been made for blood sample destruction, check reason
CL Item
Subject withdrew consent for PGx (3)
CL Item
Other (Z)
request for blood sample destruction other reason
Item
If other reason applied, specify
text
Back to the top of the page 

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial